Tower Research Capital (TRC)’s Tema Neuroscience and Mental Health ETF MNTL Stock Holding History

Tower Research Capital (TRC)’s Portfolio MNTL Stock Details MNTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-436	Closed	-$10.7K	–	5567
2024 Q4	$10.7K	Hold	436	–	–	﹤0.01%	3786
2024 Q3	$11.5K	Sell	436 -16	-4%	-$427	﹤0.01%	3659
2024 Q2	$11.6K	Sell	452 -39	-8%	-$971	﹤0.01%	4070
2024 Q1	$12.8K	Buy	+491	New	+$12.7K	﹤0.01%	3443

Other funds holding MNTL

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s MNTL Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Tema Neuroscience and Mental Health ETF (MNTL) in Q1 2025, closing a stake of 436 shares — an estimated $10.7K sold.

Tower Research Capital (TRC) first reported a position in MNTL in Q1 2024 and held it in 4 quarters. The position peaked at $12.8K in Q1 2024. 3 funds tracked by Wall St. Rank hold MNTL as of Q1 2025.

Tower Research Capital (TRC) reported no remaining Tema Neuroscience and Mental Health ETF position as of Q1 2025 after selling out during the quarter.
Tower Research Capital (TRC) sold 436 Tema Neuroscience and Mental Health ETF shares in Q1 2025, an estimated $10.7K.
Tower Research Capital (TRC) first reported a position in Tema Neuroscience and Mental Health ETF in Q1 2024 and held it in 4 quarters.
Tower Research Capital (TRC)'s Tema Neuroscience and Mental Health ETF position peaked at $12.8K in Q1 2024.
3 funds tracked by Wall St. Rank held Tema Neuroscience and Mental Health ETF as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.